Shareholdings
| Concept |
2023-04-01 to 2024-03-31 |
As at 2024-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues | — |
70
xbrli:pure
|
| Carrying amount | — |
10,002,000,000
JPY
|
| Number of issues whose number of shares increased |
4
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
4,024,000,000
JPY
|
— |
| Reason for increase in number of shares |
宇宙機器・サブシステム、往還機および商用宇宙ステーションを開発する米国発のベンチャー企業や構造タンパク質素材を開発するバイオベンチャーなど、先進技術を軸とした新規事業の推進を目的とした投資を中心に事業投資を行いました。
|
— |
| Number of issues whose number of shares decreased |
3
xbrli:pure
|
— |
| Total sale amount for decreased shares |
14,000,000
JPY
|
— |
| Shares other than those not listed | ||
| Number of issues | — |
27
xbrli:pure
|
| Carrying amount | — |
25,555,000,000
JPY
|
| Number of issues whose number of shares increased |
3
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
5,000,000
JPY
|
— |
| Reason for increase in number of shares |
取引関係の維持・拡大を目的に出資しております。
更なる関係強化を目的に持株会に加入し、株式の追加取得を行っております。
|
— |
| Number of issues whose number of shares decreased |
1
xbrli:pure
|
— |
| Total sale amount for decreased shares |
115,000,000
JPY
|
— |